Rohit Ojha

Associate Professor

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Research Cancer Research professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Rohit Ojha is an Associate Professor at the Burnett School of Medicine in the United States. His research primarily focuses on health services for patients with opioid use disorder, HCV screening during pregnancy, and cancer treatment decision support. Additionally, he investigates the interactions of dietary supplements among cancer survivors and the disparities in care for socioeconomically marginalized populations. His recent publications reflect a commitment to improving patient outcomes and addressing health inequities.

Articles (12)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (1)

Fang Fang Zhang

Tufts University Friedman School of Nutrition Science and Policy

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Rohit Ojha

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Dietary supplement use among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort Study

Survival After Implementation of a Decision Support Tool to Facilitate Evidence-Based Cancer Treatment

Eliminating Food Insecurity in the United States.

Effect of 2018 American College of Cardiology/American Heart Association Guideline Change on Statin Prescription for People Living with HIV.

Emergency Department Bridge Model and Health Services Use Among Patients With Opioid Use Disorder.

Physician-level determinants of HCV screening during pregnancy in a U.S. sample.

Cardiotoxicity among socioeconomically marginalized breast cancer patients.

Timing of adjuvant chemotherapy initiation and mortality among colon cancer patients at a safety-net health system.

The data‐collection on adverse effects of anti‐HIV drugs (D:A:D) model for predicting cardiovascular events: External validation in a diverse cohort of people living with HIV

Impact of prognostic factor distributions on mortality disparities for socioeconomically disadvantaged cancer patients.

Brief Report: HIV Pre-Exposure Prophylaxis Prescribing in an Urban Safety-Net Health System.

Knowledge needs for implementing HIV pre-exposure prophylaxis among primary care providers in a safety-net health system

Collaborators (1)

Fang Fang Zhang

Make your next move.